Please provide your email address to receive an email when new articles are posted on . Research shows nearly 20% of patients with pemphigus experience relapse. An additional dose of rituximab in ...
A study of patients with pemphigus who were in remission after a rituximab cycle found that administering an additional infusion at month 6, when guided by relapse predictors, significantly improved ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — An initial double dose of pneumococcal vaccine improves immune response against pneumococcal ...
Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity PURPOSE: To conduct a ...
Small studies have found that B-cell depletion with rituximab may be beneficial in refractory antineutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitis, due to the presence of ...
ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results